These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18405183)

  • 21. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    Kannangara AP; Levitan D; Fleischer AB
    J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene.
    Mehlmauer MA
    Cutis; 2004 Jun; 73(6):417-20. PubMed ID: 15224787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective treatment of a case of refractory mycosis fungoides with imatinib.
    Oka S; Yokote T; Hara S; Akioka T; Kobayashi K; Hirata Y; Yamano T; Endo Y; Tsuji M; Hanafusa T
    Br J Haematol; 2006 May; 133(4):353. PubMed ID: 16643439
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of radiation therapy in mycosis fungoides refractory to systemic therapy.
    de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM
    Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bexarotene monotherapy for patients with refractory Sézary syndrome.
    Staib G; Scharffetter-Kochanek K
    Dermatol Clin; 2008 Jan; 26 Suppl 1():61-3. PubMed ID: 18405190
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical bexarotene for psoralen plus ultraviolet A-induced photodamage.
    Deonizio JM; Vaghani SP; Guitart J
    J Am Acad Dermatol; 2013 Aug; 69(2):e96-8. PubMed ID: 23866897
    [No Abstract]   [Full Text] [Related]  

  • 27. Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate.
    Steinhoff M; Beyer M; Roewert-Huber J; Lukowsky A; Assaf C; Sterry W
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S88-91. PubMed ID: 18489056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folliculotropic mycosis fungoides responding to bexarotene gel.
    Walling HW; Swick BL; Gerami P; Scupham RK
    J Drugs Dermatol; 2008 Feb; 7(2):169-71. PubMed ID: 18335654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of multiple basal cell carcinomas in mycosis fungoides treated with oral bexarotene.
    Calzavara-Pinton P; Leali C; Venturini M; Sala R; Zane C
    Eur J Dermatol; 2007; 17(4):341-2. PubMed ID: 17540649
    [No Abstract]   [Full Text] [Related]  

  • 30. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
    Wirtz M; Helbig D
    Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photochemotherapy in mycosis fungoides--a study of fifty-six patients [proceedings].
    Warin AP; Briffa DV; Harrington CI; Bleehen SS
    Br J Dermatol; 1979 Jul; 101 Suppl 17():25. PubMed ID: 465325
    [No Abstract]   [Full Text] [Related]  

  • 32. Bexarotene monotherapy for epidermotropic CD8+ CTCL.
    Kamstrup M; Gniadecki R
    Dermatol Clin; 2008 Jan; 26 Suppl 1():45-7. PubMed ID: 18405187
    [No Abstract]   [Full Text] [Related]  

  • 33. Follicular mycosis fungoides: variability of a rare entity.
    Roeschm A; Schleyer V; Landthaler M; Vogt T
    Skinmed; 2005; 4(1):12-7. PubMed ID: 15654159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides.
    Lokitz ML; Wong HK
    Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of CD30+ large cell lymphoma of skin to bexarotene.
    Keun YK; Woodruff R; Sangueza O
    Leuk Lymphoma; 2002 May; 43(5):1153-4. PubMed ID: 12148901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycosis fungoides responding to photopheresis.
    Oncology (Williston Park); 1989 Jul; 3(7):36. PubMed ID: 2641913
    [No Abstract]   [Full Text] [Related]  

  • 37. Foreign-body-associated granulomatous slack skin in folliculotropic mycosis fungoides of childhood.
    Tronnier M
    J Cutan Pathol; 2009 May; 36(5):578-81. PubMed ID: 19476528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.
    Talpur R; Duvic M
    Clin Lymphoma Myeloma; 2006 May; 6(6):488-92. PubMed ID: 16796781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycosis fungoides? Sezary syndrome.
    Roenigk HH; Taylor JG
    Arch Dermatol; 1970 Feb; 101(2):244-6. PubMed ID: 4244178
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term control of mycosis fungoides of the hands with topical bexarotene.
    Lain T; Talpur R; Duvic M
    Int J Dermatol; 2003 Mar; 42(3):238-41. PubMed ID: 12653924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.